| Announce Date | 11/12/2025 |
| EPS Normalized Actual | $0.84 (Beat by $0.1) |
| EPS GAAP Actual | $0.84 (Beat by $0.1) |
| Revenue Actual | $17.309B |
| Revenue Surprise | Beat by $17309M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.99812 |
| EPS GAAP Estimate | $0.99812 |
| Revenue Estimate | $13.113181625B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 5.04964 | 7.28 | 4.51731 | 5.58197 | 1 |
| Dec 2027 | 4.13 | 8.9 | 4.13 | 4.13 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.03 | 0.01915 | 17.309B | 15.62% | -6585.75M |
| FQ2 2025 (Jun 2025) | 0.99 | 0.03657 | 15.418B | 15.77% | -6304.5M |
| FQ1 2025 (Mar 2025) | 0.25 | -0.70202 | 4.411B | -184.54% | -8629.35M |
| FQ4 2024 (Dec 2024) | 0 | -0.90802 | 5.756B | -50.96% | -7266.21M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 14.605B | 36.62% | 14605M |
| FQ2 2024 (Jun 2024) | 0.58 | 0.58 | 12.986B | 8.45% | 12986M |
| FQ1 2024 (Mar 2024) | 0.45 | 0.45 | 12.551B | 20.33% | 12551M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 8.689B | -70.96% | 8689M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.99812
Consensus Revenue Estimates
13.113181625B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.25048 | -- | 1.25048 | 1.25048 | 2 |
| FQ3 2027 (Sep 2027) | 1.30063 | -- | 1.30063 | 1.30063 | 2 |
| FQ2 2027 (Jun 2027) | 1.20771 | -- | 1.20771 | 1.20771 | 2 |
| FQ1 2027 (Mar 2027) | 1.20392 | -- | 1.20392 | 1.20392 | 2 |
| FQ4 2026 (Dec 2026) | 1.0827 | -- | 1.0827 | 1.0827 | 3 |
| FQ3 2026 (Sep 2026) | 1.10315 | 6.63 | 1.10315 | 1.10315 | 1 |
| FQ2 2026 (Jun 2026) | 1.04244 | 5.03 | 1.04244 | 1.04244 | 1 |
| FQ1 2026 (Mar 2026) | 0.99812 | 74.95 | 0.99812 | 0.99812 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 15.8B | -- | 15.8B | 15.8B | 1 |
| FQ3 2027 (Sep 2027) | 4.52B | -- | 4.52B | 4.52B | 1 |
| FQ2 2027 (Jun 2027) | 4.51B | -- | 4.51B | 4.51B | 1 |
| FQ1 2027 (Mar 2027) | 15.68B | -- | 15.68B | 15.68B | 1 |
| FQ4 2026 (Dec 2026) | 13.17B | -- | 13.17B | 13.17B | 0 |
| FQ3 2026 (Sep 2026) | 32.58B | 46.88 | 32.58B | 32.58B | 0 |
| FQ2 2026 (Jun 2026) | 30.41B | 49.3 | 30.41B | 30.41B | 0 |
| FQ1 2026 (Mar 2026) | 13.11B | 66.36 | 13.11B | 13.11B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
2
EPS # of in-lines
2
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.01085 | 1.03 | 0.01915 | 1.86% |
| FQ2 2025 (Jun 2025) | 0.95343 | 0.99 | 0.03657 | 3.69% |
| FQ1 2025 (Mar 2025) | 0.95202 | 0.25 | -0.70202 | -280.81% |
| FQ4 2024 (Dec 2024) | 0.90802 | 0 | -0.90802 | -INF% |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0.58 | 0.58 | 100% | |
| FQ1 2024 (Mar 2024) | 0.45 | 0.45 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $23.89B | $17.31B | $-6585.75M | -38.05% |
| FQ2 2025 (Jun 2025) | $21.72B | $15.42B | $-6304.5M | -40.89% |
| FQ1 2025 (Mar 2025) | $13.04B | $4.41B | $-8629.35M | -195.63% |
| FQ4 2024 (Dec 2024) | $13.02B | $5.76B | $-7266.21M | -126.24% |
| FQ3 2024 (Sep 2024) | $0B | $14.61B | $14605M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $12.99B | $12986M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $12.55B | $12551M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $8.69B | $8689M | 100% |